GSK ANNOUNCES CAP OF $35 PER MONTH ON U.S. PATIENT OUT-OF-POCKET COSTS FOR ITS ENTIRE PORTFOLIO OF ASTHMA AND COPD INHALERS
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,655 GBX | +0.12% | +0.85% | +14.02% |
08:52am | Hipgnosis Songs Fund backs new Blackstone bid | AN |
Apr. 25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.02% | 84.13B | |
+25.83% | 661B | |
+27.69% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+15.15% | 231B | |
+4.76% | 200B | |
-9.45% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Gsk Announces Cap Of $35 Per Month On U.s. Patient Out-Of-Pocket…